EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Colistin-Conjugated Selenium Nanoparticles: A Dual-Action Strategy Against Drug-Resistant Infections and Cancer

Mais E Ahmed iD, Kholoud K Alzahrani iD, Nedal M Fahmy, Hayfa Habes Almutairi iD, Zainab H Almansour iD, Mir Waqas Alam iD

Pharmaceutics · 24.04.2025 · 17 (5) · 556

DOI: 10.3390/pharmaceutics17050556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 24.04.2025. Verfasst von Mais E Ahmed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, University of Baghdad, Jadriya, Baghdad 10071, Iraq. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: king faisal university, Baghdad University and Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Antimicrobial resistance (AMR) and therapy-resistant cancer cells represent major clinical challenges, necessitating the development of novel therapeutic strategies. This study explores the use of selenium nanoparticles (SeNPs) and colistin-conjugated selenium nanoparticles (Col-SeNPs) as a dual-function nanotherapeutic against multidrug-resistant Pseudomonas aeruginosa, antifungal-drug-resistant Candida spp., and human breast carcinoma (MCF-7) cells.

Methods

SeNPs were synthesized and characterized using UV-Vis spectroscopy, atomic force microscopy (AFM), energy-dispersive X-ray spectroscopy (EDX), X-ray diffraction (XRD), field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), and Fourier-transform infrared spectroscopy (FTIR), confirming their nanoscale morphology, purity, and stability.

Results

The antimicrobial activity of SeNPs and Col-SeNPs was assessed based on the minimum inhibitory concentration (MIC) and bacterial viability assays. Col-SeNPs exhibited enhanced antibacterial effects against P. aeruginosa, along with significant downregulation of the mexY efflux pump gene, which is associated with colistin resistance. Additionally, Col-SeNPs demonstrated superior antifungal activity against Candida albicans, C. glabrata, and C. krusei compared to SeNPs alone. The anticancer potential of Col-SeNPs was evaluated in MCF-7 cells using the MTT assay, revealing dose-dependent cytotoxicity through apoptosis and oxidative stress pathways. Although MCF-7 is not inherently drug-resistant, this model was used to explore the potential of Col-SeNPs in overcoming resistance mechanisms commonly encountered in cancer therapy. Conclusions: these findings support the promise of Col-SeNPs as a novel approach for addressing both antimicrobial resistance and cancer treatment challenges. Further in vivo studies, including pharmacokinetics and combination therapies, are warranted to advance clinical translation.

Schlagwörter

Stichwörter der Autor:innen

Candida spp.MCF-7breast cancerPseudomonas aeruginosaantimicrobial resistancecolistinselenium nanoparticles

Autor:innen und Institutionen

  • Department of Biology, College of Science, University of Baghdad, Jadriya, Baghdad 10071, Iraq.
  • Department of Biology, University College of Umluj, University of Tabuk, Umluj 71491, Saudi Arabia.
  • Department of Chemistry, College of Science, King Faisal University, P.O. Box 380, Al Ahsa 31982, Saudi Arabia.
  • Department of Biological Sciences, College of Science, King Faisal University, Al Ahsa 31982, Saudi Arabia.
  • Department of Physics, College of Science, King Faisal University, Al Ahsa 31982, Saudi Arabia.

ORCID-Profile: Mais E Ahmed, Kholoud K Alzahrani, Hayfa Habes Almutairi, Zainab H Almansour, Mir Waqas Alam

Förderung

  • king faisal university
  • Baghdad University and Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University

Zitieren

APA

Ahmed, M. E., Alzahrani, K. K., Fahmy, N. M., Almutairi, H. H., Almansour, Z. H., & Alam, M. W. (2025). Colistin-Conjugated Selenium Nanoparticles: A Dual-Action Strategy Against Drug-Resistant Infections and Cancer. Pharmaceutics, 17(5), 556. https://doi.org/10.3390/pharmaceutics17050556

Vancouver

Ahmed ME, Alzahrani KK, Fahmy NM, Almutairi HH, Almansour ZH, Alam MW. Colistin-Conjugated Selenium Nanoparticles: A Dual-Action Strategy Against Drug-Resistant Infections and Cancer. Pharmaceutics. 2025;17(5):556. doi:10.3390/pharmaceutics17050556

BibTeX
@article{Ahmed2025,
  author = {Ahmed, Mais E and Alzahrani, Kholoud K and Fahmy, Nedal M and Almutairi, Hayfa Habes and Almansour, Zainab H and Alam, Mir Waqas},
  title = {Colistin-Conjugated Selenium Nanoparticles: A Dual-Action Strategy Against Drug-Resistant Infections and Cancer},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {5},
  pages = {556},
  doi = {10.3390/pharmaceutics17050556}
}
Kostenlos starten →